Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02529813
Title CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center

acute leukemia

chronic lymphocytic leukemia

acute lymphoblastic leukemia

chronic lymphocytic leukemia/small lymphocytic lymphoma

non-Hodgkin lymphoma


Cyclophosphamide + Fludarabine + Tisagenlecleucel

Age Groups: child | senior | adult
Covered Countries USA

No variant requirements are available.